Home

Bedürftig Bunker Prozent nmd pharma aarhus Zeichen Transport Tagebuch

Management — NMD Pharma
Management — NMD Pharma

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle  Neuromuscular Transmission Disorders #BioEquity2016… "
Labiotech.eu on Twitter: "NMD Pharma, from @AarhusUni, is willing to tackle Neuromuscular Transmission Disorders #BioEquity2016… "

Tunge pengetanke klar til nye investeringer i biotekselskab fra Aarhus
Tunge pengetanke klar til nye investeringer i biotekselskab fra Aarhus

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

Management — NMD Pharma
Management — NMD Pharma

Event: Aarhus - Brew Your Own: Meet the founders - Biopeople
Event: Aarhus - Brew Your Own: Meet the founders - Biopeople

Company Presentation
Company Presentation

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

NMD Pharma ApS Annual Report for 1 January - 31 December 2017
NMD Pharma ApS Annual Report for 1 January - 31 December 2017

Management — NMD Pharma
Management — NMD Pharma

NMD Pharma
NMD Pharma

Management — NMD Pharma
Management — NMD Pharma

NMD Pharma - Inkef capital
NMD Pharma - Inkef capital

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

NMD Pharma
NMD Pharma

NMD Pharma
NMD Pharma

NMD Pharma
NMD Pharma

Nmd Pharma A/S, Aarhus N | firma | krak.dk
Nmd Pharma A/S, Aarhus N | firma | krak.dk

NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders

NMD Pharma company information, funding & investors | Dealroom.co
NMD Pharma company information, funding & investors | Dealroom.co

NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial  of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis

Big deal: NMD flexes series A muscles - Global University Venturing
Big deal: NMD flexes series A muscles - Global University Venturing

NMD Pharma - Capnova
NMD Pharma - Capnova

NMD Pharma brænder 41 mio. kr. af sin kæmpeinvestering
NMD Pharma brænder 41 mio. kr. af sin kæmpeinvestering

NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for  the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis